With 0.95 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.01 million shares. The 52-week range on VRNT shows that it touched its highest point at $37.31 and its lowest point at $14.15 during that stretch. It currently has a 1-year price target of $28.00. Beta for the stock currently stands at 1.43.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of VRNT was down-trending over the past week, with a drop of -8.42%, but this was down by -3.26% over a month. Three-month performance dropped to -22.43% while six-month performance fell -42.59%. The stock lost -52.99% in the past year, while it has lost -36.25% so far this year. A look at the trailing 12-month EPS for VRNT yields 0.78 with Next year EPS estimates of 3.20. For the next quarter, that number is 0.26. This implies an EPS growth rate of 11.78% for this year and 9.27% for next year. EPS is expected to grow by 10.60% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 19.45%.
Float and Shares Shorts:
At present, 60.25 million VRNT shares are outstanding with a float of 59.03 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for VRNT since 8 analysts follow the stock currently. There are 7 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $2.66154 being high and $2.62746 being low. For VRNT, this leads to a yearly average estimate of $2.65153. Based on analyst estimates, the high estimate for the next quarter is $0.97 and the low estimate is $0.67. The average estimate for the next quarter is thus $0.86.
